---
schema_version: "secwatch.filing_event.v1"
accession: "0001140361-24-029588"
form_type: "8-K"
ticker: "IONS"
cik: "0000874015"
company_name: "IONIS PHARMACEUTICALS INC"
filed_at: "2024-06-10T23:59:59+00:00"
generated_at: "2026-06-01T05:26:01.903251+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.3
calibrated_materiality_score: 0.15
confidence: "high"
source: SEC EDGAR
---

# Ionis shareholders elect directors and approve all proposals at 2024 AGM

## Summary
- Brett P. Monia re-elected with 120.5M votes for, 2.9M against; Michael Yang re-elected with 109.1M for, 14.2M against.
- Advisory say-on-pay approved with 118.9M for, 4.2M against (96.6% support).
- Amendment to 2011 Equity Incentive Plan to increase shares by 3.3M to 38.5M approved (96.5M for, 26.9M against).
- Ratification of Ernst & Young as independent auditors approved with 129.9M for, 3.5M against.

## SEC filing metadata
- accession: 0001140361-24-029588
- form_type: 8-K
- ticker: IONS
- cik: 0000874015
- company_name: IONIS PHARMACEUTICALS INC
- filed_at: 2024-06-10T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.3
- calibrated_materiality_score: 0.15
- confidence: high
- sec_items: 5.07, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/874015/000114036124029588/0001140361-24-029588-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/874015/000114036124029588/ef20030961_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001140361-24-029588
- JSON: https://secwatch.observer/filing/0001140361-24-029588.json
- Plain text: https://secwatch.observer/filing/0001140361-24-029588.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.